• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,183.36 -135.03
( -0.18%)
Global Indices
Nasdaq
50,030.26 645.37
(1.31%)
Dow Jones
7,453.29 78.68
(1.07%)
Hang Seng
61,747.25 1,942.84
(3.25%)
Nikkei 225
10,466.07 33.73
(0.32%)
Forex
USD-INR
96.52 0.30
(0.32%)
EUR-INR
112.16 0.19
(0.17%)
GBP-INR
129.37 0.68
(0.52%)
JPY-INR
0.61 0.00
(0.22%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
103.38
451194.94
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.85
 

A-1 consolidated net profit rises 419.05% in the March 2026 quarter
May 12,2026
Net profit of A-1 rose 419.05% to Rs 4.36 crore in the quarter ended March 2026 as against Rs 0.84 crore during the previous quarter ended March 2025. Sales rose 32.52% to Rs 145.27 crore in the quarter ended March 2026 as against Rs 109.62 crore during the previous quarter ended March 2025.

For the full year,net profit rose 64.11% to Rs 5.99 crore in the year ended March 2026 as against Rs 3.65 crore during the previous year ended March 2025. Sales rose 3.45% to Rs 342.91 crore in the year ended March 2026 as against Rs 331.49 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales145.27109.62 33 342.91331.49 3
OPM %4.822.21 -3.542.94 -
PBDT6.572.10 213 10.948.58 28
PBT5.811.18 392 8.074.99 62
NP4.360.84 419 5.993.65 64